NIFTY  9,351.85  0.49%
  SENSEX  30,133.30  0.63%
 CURRENCY  Rs  64.28/$ 70.28/€, 82.54/£
  GOLD  28,734.00  -0.28%
  SILVER  40,200.00  -0.53%
  DAX  12,467.00  0.10%
  FTSE  7,275.64  0.15%
  CAC  5,277.88  0.15%
  HANG SENG  24,578.40  0.50%
  NIKKEI  19,289.40  1.10%
  Shanghai Composite  3,140.85  0.10%
  DOW JONES  20,996.10  1.12%
  NASDAQ  6,025.49  0.70%
  S&P 500  2,388.61  0.61%
LAKSHMI VILAS BANK : Q4 PAT At Rs 52.1 Cr Vs Rs 49 Cr, Up 6.3% YoY LAKSHMI VILAS BANK : Q4 Provisions At Rs 108 Cr Vs Rs 27.1 Cr YoY LAKSHMI VILAS BANK : Q4 Gross NPA At 2.67% Vs 2.78% QoQ LAKSHMI VILAS BANK : Q4 Net NPA At 1.76% Vs 1.82% QoQ LAKSHMI VILAS BANK : To Pay Rs 2.70/Share As Dividend

Cipla Plans Open Access To HIV Drug Patent

Video:

Play this video

March 11: Cipla is hoping to revolutionize the treatment of HIV-AIDS in infants and children. Mint has reported that Cipla, which will own the intellectual property rights of a new anti-retroviral combination therapy, plans to put the technology in a free access patent pool. Mint’s C.H. Unnikrishnan shares a detailed report on the same.